The extensive research efforts put forth to elucidate the molecular mechanisms of CAD pathogenesis have indicated a potential role for the adipocyte-related proinflammatory cytokine lipocalin-2 (LCN2). The gene discussed is LCN2; the disease is coronary artery disorder.